List of insiders holdings for SANGAMO BIOSCIENCES INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR |
2025-02-26 17:30:33 | 4,202,848 0 |
4,202,848 | Form 4 |
2 | BIOGEN INC. Biogen MA Inc. 10% Owner |
2024-08-16 18:40:25 | 3,250,000 0 |
3,250,000 | Form 13G |
3 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER |
2025-02-26 17:32:37 | 1,393,405 0 |
1,393,405 | Form 4 |
4 | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY |
2025-02-26 17:32:04 | 1,374,842 0 |
1,374,842 | Form 4 |
5 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER |
2025-02-26 17:31:20 | 1,371,803 0 |
1,371,803 | Form 4 |
6 | LANPHIER EDWARD O II Director |
2017-01-13 16:47:38 | 41,663 1,252,119 |
1,293,782 | Form 5 |
7 | RA CAPITAL MANAGEMENT LLC RA Capital Healthcare Fund LP Kolchinsky Peter Former 10% Owner |
2015-09-29 17:08:59 | 1,220,209 0 |
1,220,209 | Form 13G |
8 | Kopp LeRoy C 10% Owner |
2007-07-11 13:20:06 | 735,000 277,000 |
1,012,000 | Form 3 |
9 | LOEB GARY EVP, General Counsel & Sec. |
2021-03-25 19:19:47 | 321,257 0 |
321,257 | Form 4 |
10 | Davis Gregory D Head of Research & Technology |
2025-02-26 17:33:13 | 315,538 0 |
315,538 | Form 4 |
11 | McClung David Mark EVP, Chief Operating Officer |
2023-11-28 16:19:59 | 212,471 0 |
212,471 | Form 4 |
12 | Wolff Henry Ward Exec VP & CFO |
2016-12-14 20:03:38 | 206,829 0 |
206,829 | Form 4 |
13 | Pooler Amy VP, HEAD OF RESEARCH |
2024-08-27 16:38:12 | 193,923 0 |
193,923 | Form 4 |
14 | Schott Robert J. SVP, Head of Development |
2022-03-01 17:20:46 | 186,237 0 |
186,237 | Form 4 |
15 | Gregory Philip D SVP of Research & CSO |
2015-06-03 21:06:27 | 177,082 0 |
177,082 | Form 4 |
16 | Ramelmeier Rolf Andrew EVP, Technical Operations |
2023-05-30 16:44:36 | 171,467 0 |
171,467 | Form 4 |
17 | NICHOL GEOFFREY Executive Vice President, R&D |
2015-12-15 17:11:03 | 159,676 0 |
159,676 | Form 4 |
18 | Yi Kathy EVP & Chief Financial Officer |
2019-05-17 17:41:40 | 150,512 0 |
150,512 | Form 4 |
19 | Woolfson Adrian EVP Research & Development |
2020-02-27 10:40:43 | 150,000 0 |
150,000 | Form 4 |
20 | PARKER H STEWART Director |
2024-06-06 16:25:56 | 137,600 0 |
137,600 | Form 4 |
21 | BLUFORD PETER VP, Corporate Development |
2004-10-06 17:38:46 | 135,791 1,200 |
136,991 | Form 4 |
22 | Fontenot Jason D. SVP, Chief Scientific Officer |
2023-11-28 16:18:40 | 136,270 0 |
136,270 | Form 4 |
23 | Turner Heather D EVP, General Counsel & Sec. |
2019-02-27 20:19:16 | 134,750 0 |
134,750 | Form 4 |
24 | Smith Karen L. Director |
2024-06-06 16:26:31 | 127,100 0 |
127,100 | Form 4 |
25 | Carey Robert Director |
2024-06-06 16:23:31 | 124,600 0 |
124,600 | Form 4 |
26 | Hillan Kenneth J. Director |
2024-06-06 16:23:57 | 124,600 0 |
124,600 | Form 4 |
27 | Meyers James R Director |
2024-06-06 16:25:28 | 124,600 0 |
124,600 | Form 4 |
28 | Markels John Director |
2024-06-06 16:24:55 | 121,384 0 |
121,384 | Form 4 |
29 | Horn Margaret A Director |
2024-06-06 16:24:27 | 107,650 0 |
107,650 | Form 4 |
30 | Beers Courtney Director |
2024-06-06 16:23:04 | 107,650 0 |
107,650 | Form 4 |
31 | ANDO DALE G VP, Therapeutic Dev. & CMO |
2015-12-15 17:12:42 | 107,328 0 |
107,328 | Form 4 |
32 | Lee Sung EVP, Chief Financial Officer |
2020-11-30 19:46:14 | 88,708 0 |
88,708 | Form 4 |
33 | Zakrzewski Joseph S Director |
2022-03-01 17:15:06 | 85,700 0 |
85,700 | Form 4 |
34 | Mento Steven J Director |
2018-06-12 20:26:37 | 29,332 32,214 |
61,546 | Form 4 |
35 | Ramasastry Saira Director |
2022-03-01 17:13:17 | 60,700 0 |
60,700 | Form 4 |
36 | DILLY STEPHEN GEORGE Director |
2020-06-03 16:27:37 | 35,000 0 |
35,000 | Form 4/A |
37 | Ichikawa David G Senior VP, Bus. Dev. |
2011-12-12 20:53:03 | 25,000 0 |
25,000 | Form 4 |
38 | ZANTE GREG VP, Finance & Administration |
2008-03-12 19:41:56 | 24,552 0 |
24,552 | Form 4 |
39 | CASE CASEY C VP, Research & Operations |
2004-12-22 14:12:49 | 20,000 0 |
20,000 | Form 4 |
40 | Herberts Curt A. III Sr.VP & Chief Business Officer |
2018-04-17 16:16:03 | 18,375 0 |
18,375 | Form 4 |
41 | Conner Edward R. Sr. VP & Chief Medical Officer |
2019-01-28 17:46:59 | 11,291 0 |
11,291 | Form 4 |
42 | GERBER WILLIAM G Director |
2010-06-03 17:01:32 | 10,000 0 |
10,000 | Form 4 |
43 | WIGGANS THOMAS G Director |
2011-06-03 17:33:11 | 10,000 0 |
10,000 | Form 4 |
44 | LARSON JOHN WILLIAM Director |
2015-06-24 17:05:42 | 10,000 0 |
10,000 | Form 4 |
45 | RUTTER WILLIAM J Director |
2004-06-14 14:06:14 | 10,000 0 |
10,000 | Form 4 |
46 | Cleveland Paul B Director |
2016-06-15 20:24:16 | 10,000 0 |
10,000 | Form 4 |
47 | WOOD MICHAEL C Director |
2008-06-06 17:46:46 | 10,000 0 |
10,000 | Form 4 |
48 | Liu Margaret Director |
2008-06-06 17:45:38 | 10,000 0 |
10,000 | Form 4 |
49 | JACOBY JON E M Director |
2005-06-07 12:02:33 | 10,000 0 |
10,000 | Form 4 |
50 | JEFFS ROGER Director |
2018-09-07 19:18:12 | 9,908 0 |
9,908 | Form 4 |
51 | RINGO WILLIAM R Director |
2017-09-22 16:04:42 | 800 0 |
800 | Form 4 |
52 | Boissel Stephane EVP, Corp. Strategy |
2020-07-31 20:16:25 | 3 0 |
3 | Form 4 |